- Lexicon Pharmaceuticals (NASDAQ:LXRX -6.5%) Q2 results: Revenues: $0.4M (-42.9%); R&D Expense: $20.8M (-1.9%); SG&A: $6.3M (+21.2%); Operating Loss: ($26.7M) (-2.3%); Net Loss: ($28.1M) (-8.1%); Loss Per Share: ($0.27) (+22.9%); Quick Assets: $282.5M (-16.7%).
- No guidance given.
Lexicon Pharma reports Q2 results
Recommended For You
More Trending News
About LXRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LXRX | - | - |
Lexicon Pharmaceuticals, Inc. |